NCT04815226View on ClinicalTrials.gov

The Role of Active Administration of Peristeen Bowel Evacuation for the Management of Urinary Tract Infection

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Neurogenic BladderNeurogenic BowelSpina BifidaFecal IncontinenceFecal ImpactionUrinary Incontinence
Interventions
DEVICE

Peristeen Transanal Irrigation

Using Peristeen Transanal Irrigation twice per week for 12 weeks

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

Coloplast A/S
All Listed Sponsors
collaborator

Coloplast A/S

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT04815226 - The Role of Active Administration of Peristeen Bowel Evacuation for the Management of Urinary Tract Infection | Biotech Hunter | Biotech Hunter